10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.   20549

___________________________________

FORM 10-Q

___________________________________

Quarterly Report Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

For the Quarterly Period Ended September 30, 2010

Commission File Number:  1-34208

EMERGENT GROUP INC.

(Exact name of registrant as specified in its charter)

Nevada	93-1215401
(State of jurisdiction of Incorporation)	(I.R.S. Employer Identification No.)

10939 Pendleton Street

Sun Valley, CA 91352

(Address of principal executive offices)

(818) 394-2800

(Registrant’s telephone number)

Not Applicable

 (Former name, address and fiscal year, if changed since last report)

___________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ý   No  o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the 12 preceding months (or such shorter period that the registrant was required to submit and post such file). Yes [ ]  No [    ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

     Large accelerated filer o Accelerated filer o

 Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company ý

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  o   No  ý

As of November 4, 2010, the registrant had a total of 6,897,949 shares of Common Stock outstanding.

1

EMERGENT GROUP INC.

FORM 10-Q Quarterly Report

Table of Contents

		Page
PART I.  FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets as of September 30, 2010 (unaudited)
	and December 31, 2009	3
	Condensed Consolidated Statements of Income for the Three and Nine Months
	Ended September 30, 2010 and 2009 (unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended
	September 30, 2010 and 2009 (unaudited)	5
	Notes to Condensed Consolidated Financial Statements (unaudited)	6
Item 2.	Management’s Discussion and Analysis of Financial Condition
	and Results of Operations	11
Item 3.	Quantitative and Qualitative Disclosures and Market Risk	15
Item 4.	Controls and Procedures	15
PART II.  OTHER INFORMATION
Item 1.	Legal Proceedings	16
Item1A.	Risk Factors	16
Item 2.	Changes in Securities	16
Item 3.	Defaults Upon Senior Securities	16
Item 4.	Reserved	16
Item 5.	Other Information	16
Item 6.	Exhibits	16
Signatures		17

2

PART I.  FINANCIAL INFORMATION

Item 1.  Financial Statements

Emergent Group Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
	September 30,			December 31,
	2010			2009
ASSETS	(Unaudited)
Current assets
Cash	$	7,283,073		$	7,427,165
Accounts receivable, net of allowance for doubtful
accounts of $98,909 and $83,704		3,803,026			4,006,123
Inventory, net		1,130,668			889,526
Prepaid expenses		299,523			380,825
Deferred income taxes		257,630			557,630
Total current assets		12,773,920			13,261,269
Property and equipment, net of accumulated depreciation and
amortization of $10,304,504 and $9,031,136		4,681,577			5,545,492
Goodwill		1,120,058			1,120,058
Deferred income taxes		21,126			21,126
Other intangible assets, net of accumulated amortization of
$372,373 and $300,672		393,564			455,265
Deposits and other assets		82,671			80,992
Total assets	$	19,072,916		$	20,484,202
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Current portion of capital lease obligations	$	1,834,276		$	1,901,272
Dividends payable		-			2,710,817
Accounts payable		1,671,098			1,440,122
Accrued expenses and other liabilities		2,010,296			2,456,315
Total current liabilities		5,515,670			8,508,526
Capital lease obligations, net of current portion		1,872,710			2,670,942
Total liabilities		7,388,380			11,179,468
Commitments and contingencies, note 5		-			-
Shareholders' equity
Preferred stock, $0.001 par value, non-voting 10,000,000
shares authorized, no shares issued and outstanding		-			-
Common stock, $0.04 par value, 100,000,000 shares authorized
6,897,024 and 6,776,118 shares issued and outstanding		275,877			271,042
Additional paid-in capital		16,753,421			16,507,958
Accumulated deficit		(5,786,081	)		(8,062,324	)
Total Emergent Group equity		11,243,217			8,716,676
Non-controlling interest		441,319			588,058
Total shareholders' equity		11,684,536			9,304,734
Total liabilities and shareholders' equity	$	19,072,916		$	20,484,202

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

Emergent Group Inc. and Subsidiaries
Condensed Consolidated Statements of Income
(Unaudited)
	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2010			2009			2010			2009
Revenue	$	7,594,715		$	7,981,464		$	22,214,727		$	23,105,272
Cost of goods sold		4,607,609			4,802,495			13,465,898			13,839,056
Gross profit		2,987,106			3,178,969			8,748,829			9,266,216
Selling, general, and administrative expenses		1,566,503			1,490,174			4,522,235			4,442,338
Income from operations		1,420,603			1,688,795			4,226,594			4,823,878
Other income (expense)
Interest expense, net		(64,410	)		(85,692	)		(210,496	)		(261,681	)
Gain on disposal of property and equipment		-			5,500			64,323			8,050
Other income from affiliated entities, net		-			-			190,221			-
Other income, net		978			76			1,923			30,336
Total other income (expense)		(63,432	)		(80,116	)		45,971			(223,295	)
Income before provision for income taxes and
non-controlling interest		1,357,171			1,608,679			4,272,565			4,600,583
Provision for income taxes		(472,755	)		(553,000	)		(1,550,044	)		(1,604,634	)
Income before non-controlling interest		884,416			1,055,679			2,722,521			2,995,949
Non-controlling interests in income of consolidated
limited liability companies		(174,380	)		(225,023	)		(446,277	)		(597,030	)
Net income	$	710,036		$	830,656		$	2,276,244		$	2,398,919
Basic earnings per share	$	0.10		$	0.12		$	0.33		$	0.36
Diluted earnings per share	$	0.10		$	0.12		$	0.32		$	0.34
Basic weighted average shares outstanding		6,875,040			6,745,663			6,841,176			6,710,175
Diluted weighted-average shares outstanding		7,045,049			7,089,598			7,020,315			7,059,774

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Emergent Group Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)
	Nine Months Ended
	September 30,
	2010			2009
Cash flows from operating activities
Net income	$	2,276,244		$	2,398,919
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation and amortization		1,773,679			1,620,057
Gain on disposal of property and equipment		(64,323	)		(8,050	)
Provision for doubtful accounts		15,205			21,415
Non-controlling interest in income		446,277			597,030
Stock-based compensation		220,230			170,494
Deferred income taxes		300,000			1,217,122
Other income from affiliated entities, net		(190,221	)		-
Other expense		-			5,497
(Increase) decrease in assets and liabilities
Accounts receivable		187,892			(547,292	)
Inventory		(241,142	)		2,315
Prepaid expenses		81,302			(89,329	)
Deposits and other assets		(11,679	)		(125,377	)
Increase (decrease) in
Accounts payable		215,976			396,288
Accrued expenses and other liabilities		(413,428	)		262,699
Net cash provided by operating activities		4,596,012			5,921,788
Cash flows from investing activities
Purchase of property and equipment		(362,110	)		(517,582	)
Cash paid to members of limited liability companies		(446,637	)		(703,404	)
Contributions from new members to limited liability companies		11,250			112,500
Proceeds from the sale of property and equipment		164,169			4,050
Net cash used in investing activities		(633,328	)		(1,104,436	)
Cash flows from financing activities
Payments on capital lease obligations		(1,554,092	)		(1,492,241	)
Payments on dividends declared		(2,710,817	)		(1,989,750	)
Proceeds from equipment refinancing		128,064			34,740
Proceeds from exercise of options to purchase common stock		30,069			1,600
Net cash used in financing activities		(4,106,776	)		(3,445,651	)
Net increase (decrease) in cash		(144,092	)		1,371,701
Cash, beginning of period		7,427,165			4,586,107
Cash, end of period	$	7,283,073		$	5,957,808
Supplemental disclosures of cash flow information:
Interest paid	$	233,104		$	273,343
	$	-
Income taxes paid	$	1,251,738		$	502,147
Supplemental schedule of noncash investing and financing activities:
During the nine months ended September 30, 2010 and 2009, the Company incurred capital lease obligations
of $688,864 and $918,266, respectively, for medical equipment. In addition, equipment purchases
of $195,000 are included in accounts payable in the accompanying balance sheet as of September 30, 2010
for which the Company is arranging lease financing.

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

EMERGENT GROUP INC and SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Three and Nine Months Ended September 30, 2010 and 2009

(unaudited)

1.   BUSINESS

Emergent Group Inc. (“Emergent”) is the parent company of PRI Medical Technologies, Inc. (“PRI Medical”), its wholly owned subsidiary. Emergent and PRI Medical are referred to collectively hereinafter as the “Company” or “we”. PRI Medical provides mobile laser/surgical services, along with technical support, on a per procedure basis to hospitals, out-patient surgery centers, and physicians' offices.

2.   BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements of Emergent have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which are of a normal rec urring nature, necessary for a fair presentation of the results for the periods presented.

The results of operations presented for the three and nine months ended September 30, 2010 and 2009 are not necessarily indicative of the results to be expected for any other interim period or any future fiscal year.

Principles of Consolidation

The consolidated financial statements include the accounts of Emergent and its wholly owned subsidiaries. Also, in accordance with the guidance issued by the Financial Accounting Standards Board (“FASB”), the Company has accounted for its non-controlling interest in investments in certain limited liability companies under the full consolidation method. All significant intercompany transactions and balances have been eliminated through consolidation.

Use of Estimates

The preparation of the condensed consolidated financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of income and expenses during the reporting period. Actual results could differ significantly from those estimates.

Accounts Receivable and Concentration of Business and Credit Risks

We market our services primarily to hospitals, out-patient centers and physicians throughout 16 states located in the Western and Eastern United States. Our equipment rental and technician services are subject to competition from other similar businesses. Our accounts receivable represent financial instruments with potential credit risk. We offer credit terms and credit limits to most of our customers based on the creditworthiness of such customers. However, we retain the right to place such customers on credit hold should their account become delinquent. We maintain an allowance for doubtful accounts for estimated losses should customers fail to make required payments. In addition, we monitor the age of customer account balances, historical bad debt experience, customer creditworthiness, customer specific information, and changes in payment patterns when making estimates of the collectibility of trade receivables. Accounts receivable are written off when all collection attempts have failed. Our allowance for doubtful accounts will be increased if circumstances warrant. Based on the information available, management believes that our net accounts receivable are collectible.

Inventory

Inventory consists of finished goods primarily used in connection with the delivery of our mobile surgical equipment rental and services business. Inventory is stated at the lower of cost or market, on a first-in, first-out basis.

6

Stock-Based Compensation

On May 5, 2009, the Board approved establishing an Employee Benefit and Compensation Plan (the "2009 Plan") covering 300,000 shares with an effective date of June 29, 2009, the date of shareholder ratification of the 2009 Plan. The 2009 Plan will terminate and no awards may be granted after June 28, 2019. In April 2002, the Company adopted the 2002 Employee Benefit and Consulting Services Compensation Plan (the “2002 Plan”) under which we may issue a total of 650,000 options and awards. Our 2009 and 2002 Plans are substantially identical, except as to the number of shares covered by each respective plan and the 2009 Plan permits issuance of incentive stock options. The Plans were established for the purpose of providing incentives to key employees, officers, directors, and consultants of the Company who provide significant services to the Company. The 2009 and 2002 Plans are collectively referred to herein as the "Plans." No stock options have been issued under our 2009 Plan.

Compensation costs related to stock options issued under the Plans are determined in accordance with guidance issued by the FASB. We determine the fair value of option grants based on the Black-Scholes option-pricing model using the modified prospective method. Under this method, compensation cost recognized during the three and nine months ended September 30, 2010 and 2009 includes compensation cost for all share-based payments granted prior to but not yet vested as of January 1, 2006, and all grants subsequent to that date, based on the grant date fair value, which is amortized over the remaining vesting period for such options.

Earnings Per Share

Basic earnings per share is computed by dividing earnings available to common shareholders by the weighted-average number of common shares outstanding. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common share equivalents had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2010		2009		2010		2009
Numerator -
Net income attributable to common
Shareholders	$	710,036	$	830,656	$	2,276,244	$	2,398,919
Denominator -
Weighted-average number of common
Shares outstanding during the period		6,875,040		6,745,663		6,841,176		6,710,175
Dilutive effect of stock options and warrants		170,009		343,935		179,139		349,599
Common stock and common stock
Equivalents used for diluted earnings per share		7,045,049		7,089,598		7,020,315		7,059,774

Recent Accounting Pronounments

In January 2010, the Financial Accounting Standards Board (“FASB”) issued ASU 2010-06, Improving Disclosures about Fair Value Measurements (“ASU 2010-06”). ASU 2010-06 requires additional disclosures about fair value measurements including transfers in and out of Levels 1 and 2 and more disaggregation for the different types of financial instruments. This ASU is effective for annual and interim reporting periods beginning after December 15, 2009 for most of the new disclosures and for periods beginning after December 15, 2010 for the new Level 3 disclosures. Comparative disclosures are not required in the first year the disclosures are required. We did not have any significant transfers in or out of Level 1 and Level 2 fair value measurements during the t hree months ended September 30, 2010.

In August 2009, the FASB issued ASU 2009-15, which changes the fair value accounting for liabilities. These changes clarify existing guidance that in circumstances in which a quoted price in an active market for the identical liability is not available, an entity is required to measure fair value using either a valuation technique that uses a quoted price of either a similar liability or a quoted price of an identical or similar liability when traded as an asset, or another valuation technique that is consistent with the principles of fair value measurements, such as an income approach (e.g., present value technique). This guidance also states that both a quoted price in an active market for the identical liability and a quoted price for the identical liability when traded as an asset in an active market when no adjustments to the quo ted price of the asset are required are Level 1 input fair value measurements. This ASU became effective for us on January 1, 2010. Adoption of this ASU did not have a material impact on our consolidated financial statements.

7

In June 2009, the FASB issued accounting guidance contained within ASC 810, Consolidation (“ASC 810”), regarding the consolidation of variable interest entities (formerly SFAS No. 167, Amendments to FASB Interpretation No. 46(R)). ASC 810 is intended to improve financial reporting by providing additional guidance to companies involved with variable interest entities and by requiring additional disclosures about a company’s involvement in variable interest entities. This standard is effective for interim and annual periods beginning after November 15, 2009. Our adoption of this ASC on January 1, 2010 had no material impact on our consolidated financial statements.

In June 2009, the FASB issued ASC 860, Transfers and Servicing (“ASC 860”), (formerly SFAS No. 166, Accounting for Transfers of Financial Assets). ASC 860 requires more information about transfers of financial assets and where companies have continuing exposure to the risk related to transferred financial assets. It eliminates the concept of a qualifying special purpose entity, changes the requirements for derecognizing financial assets, and requires additional disclosure. This standard is effective for interim and annual periods beginning after November 15, 2009. We adopted this standard on January 1, 2010. The adoption of this standard had no material impact on our financial statements.

3.     DEBT OBLIGATIONS

The Company maintains a $1.5 million line of credit under a revolving credit agreement (the “Agreement”) with a bank which is collateralized by substantially all unencumbered assets of the Company. Advances under the Agreement bear interest at the prime rate, plus one-half of one percent (3.75% as of September 30, 2010), with interest payable monthly. Subject to the terms of the Agreement, the Company may request and repay advances from time to time through the expiration date. The Agreement includes certain financial covenants that must be met including a covenant that for a period of not less than thirty (30) consecutive days during the loan term, that no loan amount will be outstanding under the Agreement. The Agreement expires on December 3, 2010. As of September 30, 2010 the Company was in compliance with the terms of its revolving credit agreement and no amounts have been drawn under this facility.

In connection with an acquisition of assets during 2008, we entered into an equipment lease financing loan with a bank for $1,750,000. The equipment lease is collateralized by the acquired assets and other assets of the Company and provides for monthly payments of principal and interest of $46,378 commencing on September 1, 2008 over 42 months, with interest at 6.4%. The lease financing agreement also requires the Company to meet certain financial covenants over the loan term. As of September 30, 2010 the Company was in compliance with terms of this loan agreement.

The Company incurred total net interest expense of $64,410 and $85,692 for the three months ended September 30, 2010 and 2009, respectively and $210,496 and $261,681 for the nine months ended September 30, 2010 and 2009, respectively.

4.     STOCK OPTION PLANS

The Company issues stock options and awards for the purpose of providing incentives to key employees, officers, directors, and consultants of the Company who provide significant services to the Company. Options and awards granted under the Plans generally vest over five years and are subject to forfeiture if the employee terminates prior to vesting. As of September 30, 2010 there have been no options or awards granted under our 2009 Plan. With regard to our 2002 Plan, there are 650,000 common shares authorized for grant and such options will not be granted for a term of more than ten years from the date of grant. The 2002 Plan expires in March 2012. Incentive stock options granted under the 2002 Plan are non-statutory stock options. As of September 30, 2010, the number of shares reserved for future awards was 55,430, which is net of t he 45,000 and 53,500 restricted award shares granted in March 2010 and April 2009 under the 2002 Plan, respectively, as discussed below.

During the nine months ended September 30, 2010 and 2009 we issued -0- and 30,000, stock options, respectively, under our 2002 Plan to various employees. Such options vest in equal installments over five years and unvested options are subject to forfeiture should the respective employee leave the company. Compensation costs related to total stock options outstanding for the three months ended September 30, 2010 and 2009 were $2,595 and $3,858 respectively, and $8,715 and $11,420 for the nine months ended September 30, 2010 and 2009, respectively.

8

A summary of the Company's outstanding stock options and activity is as follows:

	Number of Options			Weighted Average Exercise Price
Outstanding at January 1, 2010		305,965		$	2.34
Options Granted		-		$	-
Options Exercised		(79,408	)	$	0.65
Options Canceled		(11,731	)	$	6.32
Outstanding at September  30, 2010		214,826		$	2.75
Exercisable at September 30, 2010		172,262		$	2.34

The weighted-average remaining contractual life of the options outstanding at September 30, 2010 is 4.38 years. The exercise prices for the options outstanding at September 30, 2010 ranged from $0.40 to $51.00 and information relating to these options is as follows:

						Weighted	Weighted	Weighted		Weighted
						Average	Average	Average		Average
						Remaining	Remaining	Exercise		Exercise
Range of		Stock		Stock		Contractual	Contractual	Price of		Price of
Exercise		Options		Options		Life of Options	Life of Options	Options		Options
Prices		Oustanding		Exercisable		Outstanding	Exercisable	Outstanding		Exercisable
$	0.40		144,576		144,576	2.94 years	2.94 years	$	0.40	$	0.40
$	2.15 - 8.00		64,000		21,436	7.93 years	7.42 years	$	4.41	$	4.45
$	20.00 - 51.00		6,250		6,250	1.08 years	1.08 years	$	40.00	$	40.00
$	0.40 - 51.00		214,826		172,262	4.38 years	3.43 years	$	2.75	$	2.34

As of September 30, 2010, the total unrecognized compensation cost related to unvested stock options was $33,903, which is to be recognized over a remaining weighted average vesting period of approximately 3.09 years.

In addition to options granted under the 2002 Plan, as of September 30, 2010, we have 424,997 restricted award shares issued and outstanding of which 328,497 were issued outside of the 2002 Plan and 205,900 are fully vested. Award shares vest in equal installments over five years from the date of issuance. Such award shares are issued from time to time to executive officers, directors and employees of the Company. Non-vested award shares are subject to forfeiture in the event that the recipient is no longer employed by the Company at the time of vesting, subject to the Board’s right to waive the forfeiture provisions. Compensation expense related to such shares is determined as of the issuance date based on the fair value of the shares issued and is amortized over the related vesting period. In March 2010 and April 2009 we issue d 45,000 and 53,500 restricted shares under the 2002 Plan, respectively. The total grant date fair value related to the restricted award shares issued in March 2010 and April 2009 was $380,700 and $363,265, respectively, representing the number of restricted shares issued times the closing prices of $8.46 and $6.79 per share, respectively.

Compensation costs are amortized over the vesting period of five years. Compensation expense related to outstanding restricted award shares was $75,451 and $59,421 for the three months ended September 30, 2010 and 2009, respectively, and $211,515 and $159,074 for the nine months ended September 30, 2010 and 2009, respectively.

9

Information relating to non-vested restricted award shares is as follows:

				Weighted		Weighted
				Average		Average
				Remaining		Grant Date		Aggregate
	Number of			Contractual		Fair Value		Intrinsic
	Shares			Life (in years)		Per Share		Value
Nonvested, January 1, 2010		228,797			2.8	$	3.75	$	789,795
Granted		45,000				$	8.46
Forfeited/Cancelled		-				$	-
Vested		(53,099	)			$	3.88
Nonvested, September 30, 2010		220,698			2.4	$	4.68	$	413,675

5. COMMITMENTS AND CONTINGENCIES

From time to time, we may become involved in litigation arising out of operations in the normal course of business. As of September 30, 2010 and as of the filing date of this Form 10-Q, we are not a party to any pending legal proceedings the adverse outcome of which could reasonably be expected to have a material adverse effect on our operating results or financial position.

6.     RELATED PARTY TRANSACTIONS

Transactions with BJH Management

The services of the Company’s Chairman and Chief Executive Officer are contracted through BJH Management for a monthly fee of $15,167. In March 2010, the services agreement with BJH Management was extended to June 30, 2013.

The Company’s Chairman and Chief Executive Officer maintains his primary office in New York. In this regard, the Company reimbursed BJH Management, LLC (“BJH”), a company owned by the Company’s Chairman and Chief Executive Officer, for office rent and other reimbursable expenses totaling $19,492 and $18,073 for the three months ended September 30, 2010 and 2009, respectively, and $55,950 and $52,173 for the nine months ended September 30, 2010 and 2009, respectively.

7.     LIMITED LIABILITY COMPANIES

In connection with expanding its business, PRI Medical participates with others in the formation of Limited Liability Companies (“LLCs”) in which it will acquire either a non-controlling or controlling-interest and the remaining interests are held by other investors. These LLCs acquire certain medical equipment for use in their respective business activities which generally focus on surgical procedures. The LLCs will acquire medical equipment for rental purposes under equipment financing leases. The third party investors in each respective LLC generally provide the lease financing company with individual proportionate lease guarantees based on their respective ownership percentages in the LLCs. In addition, PRI Medical will provide such financing companies with its corporate guarantee based on its respective ownership inte rest in each LLC. In certain instances, PRI Medical has provided such financing companies with an overall corporate guarantee in connection with equipment financing transactions. In such instances, the individual investors in each respective LLC will generally indemnify PRI Medical against losses, if any, incurred in connection with its corporate guarantee. As of September 30, 2010, PRI Medical holds interests in seven active LLCs. We previously held interests in thirteen LLCs; however, during the second half of 2009, we ceased operations in six LLCs and began the wind-down and dissolution process as a result of regulatory changes.

For the three and nine months ended September 30, 2010 and 2009, in accordance with guidance issued by the FASB, the Company accounted for its equity investments in LLCs in which it holds a non-controlling interest under the full consolidation method whereby transactions between the Company and LLCs have been eliminated through consolidation.

10

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

The information contained in this Form 10-Q and documents incorporated herein by reference are intended to update the information contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009 and such information presumes that readers have access to, and will have read, the “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Risk Factors” and other information contained in such Form 10-K and other Company filings with the Securities and Exchange Commission (“SEC”).

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties, and actual results could be significantly different than those discussed in this Form 10-Q. Certain statements contained in Management's Discussion and Analysis, particularly in "Liquidity and Capital Resources," and elsewhere in this Form 10-Q are forward-looking statements. These statements discuss, among other things, expected growth, future revenues and future performance. Although we believe the expectations expressed in such forward-looking statements are based on reasonable assumptions within the bounds of our knowledge of our business, a number of fac tors could cause actual results to differ materially from those expressed in any forward-looking statements, whether oral or written, made by us or on our behalf. The forward-looking statements are subject to risks and uncertainties including, without limitation, the following: (a) changes in levels of competition from current competitors and potential new competition, (b) possible loss of significant customer(s), (c) the Company’s ability to effectively integrate into its operations new and changing medical technologies, (d) the risk of equipment vendors not making their equipment and technologies available to equipment rental and service companies such as ours, (e) the Company’s ability to meet the terms and conditions of its debt and lease obligations, (f) the potential impact of new government rules and regulations, including recently enacted healthcare reform legislation, could have a material adverse affect on our results of our operations, and (g) changes in availability or terms of workin g capital financing from vendors and lending institutions. The foregoing should not be construed as an exhaustive list of all factors that could cause actual results to differ materially from those expressed in forward-looking statements made by us. All forward-looking statements included in this document are made as of the date hereof, based on information available to the Company on the date thereof, and the Company assumes no obligation to update any forward-looking statements.

Overview

Emergent Group Inc. (“Emergent”) is the parent company of PRI Medical Technologies, Inc. (“PRI Medical”), its wholly owned subsidiary. Emergent and PRI Medical are referred to collectively hereinafter as the “Company.” PRI Medical provides mobile laser/surgical services, along with technical support, on a per procedure basis to hospitals, out-patient surgery centers, and physicians' offices.

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of financial statements requires managers to make estimates and disclosures on the date of the financial statements. On an on-going basis, we evaluate our estimates including, but not limited to, those related to revenue recognition, inventory valuation and property and equipment. We use authoritative pronouncements, historical experience and other assumptions as the basis for making judgments. Actual results could differ from those estimates. We believe that the following critical accounting policies affect our more significant judgments and estimates in the preparation of our financial stateme nts.

Revenue Recognition. Revenue is recognized once our mobile rental and technicians services are performed and billable. We are required to make judgments based on historical experience and future expectations, as to the realizability of goods and services billed to our customers. These judgments are required to assess the propriety of the recognition of revenue based on Staff Accounting Bulletin (“SAB”) No. 104, “Revenue Recognition,” and related guidance. We make such assessments based on the following factors: (a) customer-specific information, and (b) historical experience for issues not yet identified.

Inventory Valuation. We are required to make judgments based on historical experience and future expectations as to the realizability of our inventory. We make these assessments based on the following factors: (a) existing orders and usage, (b) age of the inventory, and (c) historical experience.

11

Property and Equipment. We are required to make judgments based on historical experience and future expectations as to the realizability of our property and equipment. We made these assessments based on the following factors: (a) the estimated useful lives of such assets, (b) technological changes in our industry, and (c) the changing needs of our customers.

Results of Operations

The following table sets forth certain selected unaudited condensed consolidated statements of income data for the periods indicated in dollars and as a percentage of total revenues. The following discussions relate to our results of operations for the periods noted. The results of operations are not necessarily indicative of the results expected for any other interim period or any future fiscal year. In addition, we note that the period-to-period comparison may not be indicative of future performance.

	Three Months Ended September 30,												Nine Months Ended September 30,
	2010			%			2009			%			2010			%			2009			%
Revenue	$	7,594,715			100	%	$	7,981,464			100	%	$	22,214,727			100	%	$	23,105,272			100	%
Cost of goods sold		4,607,609			61	%		4,802,495			60	%		13,465,898			61	%		13,839,056			60	%
Gross profit		2,987,106			39	%		3,178,969			40	%		8,748,829			39	%		9,266,216			40	%
Selling, general, and administrative expenses		1,566,503			21	%		1,490,174			19	%		4,522,235			20	%		4,442,338			19	%
Income from operations		1,420,603			18	%		1,688,795			21	%		4,226,594			19	%		4,823,878			21	%
Other income (expense)		(63,432	)		-1	%		(80,116	)		-1	%		45,971			0	%		(223,295	)		-1	%
Income before provision for income
taxes and non-controlling interest		1,357,171			17	%		1,608,679			20	%		4,272,565			19	%		4,600,583			20	%
Provision for income taxes		(472,755	)		-6	%		(553,000	)		-7	%		(1,550,044	)		-7	%		(1,604,634	)		-7	%
														-
Net income before non-controlling interest		884,416			11	%		1,055,679			13	%		2,722,521			12	%		2,995,949			13	%
Non-controlling interest in income of
consolidated limited liability companies		(174,380	)		-2	%		(225,023	)		-3	%		(446,277	)		-2	%		(597,030	)		-3	%
Net income	$	710,036			9	%	$	830,656			10	%	$	2,276,244			10	%	$	2,398,919			10	%

Comparison of the Three Months Ended September 30, 2010 to September 30, 2009

The Company generated revenues of $7,594,715 in 2010 compared to $7,981,464 in 2009. The decrease in revenues in 2010 of $386,749, or 5% is related to a decrease in revenues from our surgical procedures. The decrease in surgical revenues during the quarter may be attributable, in part, to current economic conditions whereby many individuals may have lost their healthcare coverage and as a result may be postponing medical procedures in the short-term.

Cost of goods sold was $4,607,609 in 2010 or 61% of revenues, compared to $4,802,495 or 60% of revenues for 2009. Costs of goods sold primarily consist of payroll costs and related expenses for technicians, cost of disposables consumed, depreciation and amortization related to equipment, insurance costs and other operating costs incurred in rendering mobile medical equipment and technician services. The overall decrease in cost of goods sold of $194,886 or 4% for 2010 is due to the decrease in revenues for the period resulting in lower overall operating costs including payroll and payroll related costs, partially offset by increases in depreciation and amortization expenses of $25,339. The increase in depreciation and amortization expense relates to equipment purchases in 2010 and 2009. The net change in other cost categories included in cost of goods sold remained relatively consistent in 2010 compared to 2009.

Gross profit from operations was $2,987,106 in 2010, compared to $3,178,969 in 2009. Gross profit as a percentage of revenues was 39% for 2010 compared to 40% for 2009. Gross profit margins after disposable costs will vary depending on the type of surgical procedure performed due to the fact that certain procedures require more expensive disposable items. In addition, gross profit margin rates will vary from period to period depending upon other factors including pricing considerations, and equipment and technician utilization rates. The gross profit margin for 2010 is not necessarily indicative of the gross profit margins that may be realized in future periods.

Selling, general, and administrative expenses were $1,566,503 and $1,490,174 for 2010 and 2009, respectively, or 21% and 19% of revenues, respectively. Such costs include, among others, payroll and related expenses, insurance costs and occupancy costs. Overall, the cost categories within selling, general and administrative expenses were relatively comparable for both 2010 and 2009.

12

Other income (expense) was $(63,432) in 2010 compared to $(80,116) in 2009. Other income (expense) includes interest income and expense, gains and losses on disposal of property and equipment, and other miscellaneous income and expense items. The net decrease in other income (expense) of $16,684 is primarily related to a decrease in net interest expense for 2010 of $21,282 primarily due to the continuing pay-down of lease obligations with higher interest rates and an increase in interest income, offset by a decrease of $5,500 in gain on disposal of property and equipment in 2010 compared to 2009.

The non-controlling interest (ownership interests held by third-parties) in net income of limited liability companies was $174,380 in 2010 compared to $225,023 in 2009. In 2010 and 2009, we held ownership interests in seven and thirteen entities, respectively. During mid to late 2009 we ceased operations in six LLCs and we began the wind-down and dissolution process. The decrease in non-controlling interest in earnings is related to the winding-down of operations for such LLCs. As of September 30, 2010 and 2009, in accordance with guidance issued by the FASB, the Company accounted for its equity investments in entities in which it holds a non-controlling interest under the full consolidation method.

Net income was $710,036 in 2010 compared to $830,656 in 2009. Provision for income taxes was $472,755 in 2010 compared to $553,000 in 2009. The provision for income taxes for both 2010 and 2009 is comprised of state and federal taxes, federal Alternative Minimum Taxes (AMT) and the utilization of deferred income tax assets. At December 31, 2009, the Company had net operating loss carryforwards of approximately $3.4 million for federal tax purposes, which is subject to certain limitations due to statutory ownership changes. Basic net income per share for 2010 and 2009 was $0.10 and $0.12, respectively, while fully diluted net income per share for 2010 and 2009 was $0.10 and $0.12, respectively. Basic and fully diluted weighted average shares outstanding for 2010 were 6,875,040 and 7,045,049, respectively, and 6,745,663 and 7,089,598 for 2009, respectively.

Comparison of the Nine Months Ended September 30, 2010 to September 30, 2009

The Company generated revenues of $22,214,727 in 2010 compared to $23,105,272 in 2009. The decrease in revenues in 2010 of $890,545, or 4%, is primarily related to a decrease in surgical procedures, which may be attributable, in part, to current economic conditions whereby many individuals may have lost their healthcare coverage and as a result may be postponing medical procedures in the short-term.

Cost of goods sold was $13,465,898 in 2010 or 61% of revenues, compared to $13,839,056 or 60% of revenues for 2009. Costs of goods sold primarily consist of payroll costs and related expenses for technicians, cost of disposables consumed, depreciation and amortization related to equipment, insurance costs and other operating costs incurred in rendering mobile medical equipment and technician services. The overall decrease in cost of goods sold of $373,158 or 3% for 2010 is primarily related to the decrease in revenues during the period resulting in lower overall operating costs including disposable costs, payroll and payroll related costs, partially offset by increases in depreciation and amortization expenses of $157,550 and equipment maintenance costs of $131,492. The increase in depreciation and amortization expense relates to equip ment purchases in 2010 and 2009. The net change in other cost categories included in cost of goods sold remained relatively consistent in 2010 compared to 2009.

Gross profit from operations was $8,748,829 in 2010 compared to $9,266,216 in 2009. Gross profit as a percentage of revenues was 39% in 2010 compared to 40% in 2009. Gross margins after disposable costs will vary depending on the type of surgical procedure performed due to the fact that certain procedures require more expensive disposable items. In addition, gross margin rates will vary from period to period depending upon other factors including pricing considerations, and equipment and technician utilization rates. The gross margin for 2010 is not necessarily indicative of the margins that may be realized in future periods.

Selling, general, and administrative expenses in 2010 were $4,522,235 compared to $4,442,338 in 2009. Selling, general, and administrative expenses as a percentage of revenues were 20% for 2010 and 19% for 2009. Such costs include, among others, payroll and related expenses, insurance costs and occupancy costs. Overall, the cost categories within selling, general and administrative expenses were relatively comparable for both 2010 and 2009.

Other income (expense) was $45,971 in 2010 compared to $(223,295) in 2009. Other income (expense) includes interest income and expense, gains and losses on disposal of property and equipment, and other miscellaneous income and expense items. The net increase in other income (expense) of $269,266 is related to other income of $190,221 from affiliated entities related to equipment acquired from such entities in 2010 while no such income items were recorded in the prior year, an increase of $56,273 in gain on disposal of property and equipment in 2010, a decrease of $51,185 in net interest expense related to the continuing pay-down of lease obligations with higher interest rates and an increase in interest income, offset by a decrease of $28,413 in miscellaneous income in 2010 compared to 2009.

13

The minority interest (ownership interests held by third-parties) in net income of limited liability companies was $446,277 in 2010 compared to $597,030 in 2009. In 2010 and 2009, we held ownership interests in seven and thirteen entities, respectively. During mid to late 2009 we ceased operations in six LLCs and we began the wind-down and dissolution process. The decrease in non-controlling interest in earnings is related to the winding-down of operations for such LLCs. As of September 30, 2010 and 2009, in accordance with guidance issued by the FASB, the Company accounted for its equity investments in entities in which it holds a non-controlling interest under the full consolidation method.

Net income was $2,276,244 in 2010 compared to $2,398,919 in 2009. Provision for income taxes was $1,550,044 in 2010 as compared to $1,604,634 in 2009. The provision for income taxes for both 2010 and 2009 is comprised of state and federal taxes, federal Alternative Minimum Taxes (AMT) and the utilization of deferred income tax assets. At December 31, 2009, the Company had net operating loss carryforwards of approximately $3.4 million for federal tax purposes, which is subject to certain limitations due to statutory ownership changes. Basic net income per share for 2010 and 2009 was $0.33 and $0.36, respectively, while fully diluted net income per share for 2010 and 2009 was $0.32 and $0.34, respectively. Basic and fully diluted weighted average shares outstanding for 2010 were 6,841,176 and 7,020,315, respectively, and 6,710,175 and 7, 059,774 for 2009, respectively.

Liquidity and Capital Resources

The Company maintains a $1.5 million line of credit under a revolving credit agreement (the “Agreement”) with a bank which is collateralized by substantially all unencumbered assets of the Company. Advances under the Agreement bear interest at the prime rate, plus one-half of one percent (3.75% as of September 30, 2010), with interest payable monthly. Subject to the terms of the Agreement, the Company may request and repay advances from time to time through the expiration date. The Agreement includes certain financial covenants that must be met including a covenant that for a period of not less than thirty (30) consecutive days during the loan term, that no loan amount will be outstanding under the Agreement. The Agreement expires on December 3, 2010 and we are in the process of renewing the Agreement as of the filing of th is Form 10-Q. In addition, as of September 30, 2010 and the filing of this Form 10-Q, the Company was in compliance with the terms of its revolving credit agreement and no amounts have been drawn under this facility.

In connection with an acquisition of assets during 2008, we entered into an equipment lease financing loan with a bank for $1,750,000. The equipment lease is collateralized by the acquired assets and other assets of the Company and provides for monthly payments of principal and interest of $46,378 commencing on September 1, 2008 over 42 months, with interest at 6.4%. The lease financing agreement also requires Emergent to meet certain financial covenants over the loan term. As of September 30, 2010 and the filing of this Form 10-Q, the Company was in compliance with terms of this loan agreement.

The Company had cash and cash equivalents of $7,283,073 at September 30, 2010. Cash provided by operating activities for the nine months ended September 30, 2010 was $4,596,012. Cash generated from operations includes net income of $2,276,244, depreciation and amortization of $1,773,679, deferred income taxes of $300,000, non-controlling interest in income of $446,277, stock-based compensation of $220,230, an increase in provision for doubtful accounts of $15,205, decreases in accounts receivable and prepaid expenses of $269,194 and an increase in accounts payable of $215,976; offset by other income from affiliated entities of $190,221, gain on disposal of property and equipment of $64,323, an increase in inventory of $241,142, an increase in deposits and other assets of $11,679 and a decrease in accrued expenses and other liabili ties of $413,428. Cash used in investing activities was $633,328 and consisted of the purchase of property and equipment of $362,110, cash distributions of $446,637 to members of limited liability companies, offset by proceeds from the sale of property and equipment of $164,169 and cash contributions from new members of limited liability companies of $11,250. Cash used for financing activities was $4,106,776 and consisted of payment of dividends on common stock of $2,710,817, payments of $1,554,092 on lease obligations; offset by proceeds of $128,064 from equipment refinancing and $30,069 from the exercise of common stock options.

The Company had cash and cash equivalents of $5,957,808 at September 30, 2009. Cash provided by operating activities for the nine months ended September 30, 2009 was $5,921,788. Cash generated from operations includes net income of $2,398,919, depreciation and amortization of $1,620,057, deferred income taxes of $1,217,122, minority interest in net income of $597,030, stock-based compensation of $170,494, an increase in provision for doubtful accounts of $21,415, and increases in accounts payable and accrued expenses of $396,288 and $262,699, respectively; and inventory and other expense-noncash of $7,812; offset by increases in accounts receivable, prepaid expenses, deposits and other assets, and gain on disposal of property and equipment of $547,292; $89,329; $125,377, and $8,050, respectively. Cash used in investing activities was $ 1,104,436 and consisted of the purchase of property and equipment of $517,582, cash distributions of $703,404 to members of limited liability companies, offset by contributions from new members to limited liability companies of $112,500 and proceeds from the sale of equipment of $4,050. Cash used for financing activities was $3,445,651 and consisted of payment of dividends on common stock of $1,989,750, and payments of $1,492,241 on lease obligations; offset by proceeds of $34,740 and $1,600 from equipment refinancing and the exercise of common stock options, respectively.

14

We anticipate that our future liquidity requirements will arise from the need to finance our accounts receivable and inventories, and from the need to fund our current debt and lease obligations and capital expenditures. The primary sources of funding for such requirements will be cash generated from operations, borrowings under debt facilities and trade payables, and raising additional capital from the sale of equity or other securities. The Company believes that it can generate sufficient cash flow from these sources to fund its on-going operations for at least the next twelve months.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk is the risk of loss arising from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates and commodity prices. Our primary exposure to market risk is interest rate risk associated with our short term money market investments. The Company does not have any financial instruments held for hedging or other speculative purposes and does not invest in derivative financial instruments, interest rate swaps or other investments that alter interest rate exposure.

Item 4. Controls and Procedures

We maintain disclosure controls and procedures, which are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commissions rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our CEO and CFO, an evaluation was performed on the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on that evaluation, our management, including our CEO and CFO, concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

There were no changes in the Company’s internal controls over financial reporting during the most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

15

PART II.  OTHER INFORMATION

.

Item 1.  Legal Proceedings

See Note 5 to Notes to Condensed Consolidated Financial Statements included herein for a description of legal matters.

Item 1A.  Risk Factors

As a  Smaller Reporting Company as defined Rule 12b-2 of the Exchange Act and in item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item 1A.

Item 2.  Changes in Securities

None.

Item 3.  Defaults Upon Senior Securities

None.

Item 4.  Reserved

Item 5.  Other Information

None

Item 6.  Exhibits

Except for the exhibits listed below, other required exhibits have been previously filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended.

Exhibit Number	Description
11.1	Statement re: computation of earnings per share.  See condensed consolidated statement of operations and notes thereto.
31(a)	Rule 13a-14(a) Certification – Chief Executive Officer *
31(b)	Rule 13a-14(a) Certification – Chief Financial Officer *
32(a)	Section 1350 Certification – Chief Executive Officer *
32(b)	Section 1350 Certification – Chief Financial Officer *
99.1	Press Release, dated November 4, 2010 Re: Quarterly Results*

* Filed herewith.

16

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	EMERGENT GROUP INC.
Date: November 5, 2010	By:	/s/ Bruce J. Haber
		Bruce J. Haber,
		Chairman and Chief Executive Officer
Date: November 5, 2010	By:	/s/ William M. McKay
		William M. McKay,
		Chief Financial Officer and Secretary

17

EX-31.A

Exhibit 31(a)

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I,  Bruce J. Haber certify that:
1.	I have reviewed this quarterly report on Form 10-Q of  Emergent Group Inc.;
2	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors:
	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 5, 2010

/s/	Bruce J. Haber
	Bruce J. Haber
	Chief Executive Officer

EX-31.B

Exhibit 31(b)

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, William M. McKay certify that:
1.	I have reviewed this quarterly report on Form 10-Q of Emergent Group Inc.;
2	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors:
	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 5, 2010

/s/	William M. McKay
	William M. McKay
	Chief Financial Officer

EX-32.A

Exhibit 32(a)

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

In connection with the Quarterly Report of Emergent Group Inc. (the “registrant”) on Form 10-Q for the quarter ended September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, Bruce J. Haber, Chief Executive Officer of the registrant, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the registrant.

November 5, 2010
/s/	Bruce J. Haber
	Bruce J. Haber
	Chief Executive Officer

EX-32.B

Exhibit 32(b)

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

In connection with the Quarterly Report of Emergent Group Inc. (the “registrant”) on Form 10-Q for the quarter ended September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, William M. McKay, Chief Financial Officer of the registrant, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the registrant.

November 5, 2010
/s/	William M. McKay
	William M. McKay
	Chief Financial Officer

EX-99.1

EXHIBIT 99.1

Press Release  Source: Emergent Group Inc.

Emergent Group Reports Third Quarter Results

SUN VALLEY, Calif., Nov. 4, 2010 (GLOBE NEWSWIRE) -- Emergent Group Inc. (NYSE Amex:LZR), a leading provider of mobile medical lasers and surgical equipment, announced the following financial results for the third quarter ended September 30, 2010:

·   Revenue decreased 4.8% to $7,594,715 versus $7,981,464 for the prior year's third quarter ended September 30, 2009 as the company noted continued softness in demand for medical procedures and related services affecting various healthcare sectors. However, third quarter revenue was 4.8% higher than the second quarter of 2010. This compared to sequential revenue growth of 2.5% between the second and third quarters of 2009.

·   EBITDA (earnings before interest, taxes, depreciation and amortization) declined 8.7% to $1,919,041 versus $2,101,177 for the prior year period.

·   Net income decreased 14.5% to $710,036, or $0.10 per diluted share, for the third quarter of 2010, versus $830,656, or $0.12 per diluted share, in the prior year period. Diluted weighted-average shares outstanding were lower in the current quarter at 7,045,049 versus 7,089,598 for the prior year period.

·   At the end of the quarter, the company had a cash balance of $7,283,073, amounting to $1.03 per diluted share.

 "With Emergent Group's strong position in the marketplace and our strategic focus on sales," said Chairman and CEO Bruce J. Haber, "we were pleased to see sequential revenue growth between the second and third quarters despite the persistent softness that various healthcare sectors have experienced in overall demand for medical products and services. Although the economic downturn has caused some Americans to lose health insurance or postpone certain medical procedures, we continue to believe that not all such procedures can be delayed indefinitely. Thus, we have confidence that the current softness is a short-term phenomenon and we look forward to a recovery in the near future." 

"Furthermore," Haber added, "we know that Emergent Group's business model remains attractive in the current economic climate as rentals allow our hospital and physician practice customers to conserve cash and still embrace the latest technologies. Rentals also give equipment manufacturers opportunities to partner with us and thereby extend their distribution channels beyond the typically long sales cycles. Thus, our strategic position and value proposition bode well for the future of Emergent Group."

The company reported the following financial results for the nine months ended September 30, 2010:

·   Revenue decreased 3.9% to $22,214,727 versus $23,105,272 for the prior year period ended September 30, 2009.

·   EBITDA (earnings before interest, taxes, depreciation and amortization) declined 0.4% to $6,030,693 versus $6,055,785 for the prior year period. 

·   Net income decreased 5.1% to $2,276,244, or $0.32 per diluted share, for the first nine months of 2010, versus $2,398,919, or $0.34 per diluted share, in the prior year period.  Diluted weighted-average shares outstanding were slightly lower for the latest nine months at 7,020,315 versus 7,059,774 for the prior year period.

About Emergent Group Inc.

Emergent Group Inc., through its wholly owned subsidiary, PRI Medical Technologies, Inc. ("PRI Medical"), provides mobile medical laser and surgical equipment in 16 states on a per-procedure basis to hospitals, outpatient surgery centers and physicians' offices. Surgical equipment is provided to customers along with technical support personnel to ensure that such equipment is operating correctly. PRI Medical currently offers its services in five states in the western United States and 11 states along the eastern seaboard. Emergent Group Inc. is a member of the Russell Microcap® Index. For investor and product information, visit Emergent Group's website, www.emergentgroupinc.com.

Forward-Looking Statements

Statements in this news release may contain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934. Such statements may involve various risks and uncertainties, some of which may be discussed in the Company's most recent report on Form 10-K and subsequently filed SEC reports. There is no assurance any forward-looking statements will prove accurate, as actual results and future events could differ materially from those presently anticipated.

Emergent Group Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

	September 30,			December 31,
	2010			2009
ASSETS	(Unaudited)
Current assets
Cash	$	7,283,073		$	7,427,165
Accounts receivable, net of allowance for doubtful
accounts of $98,909 and $83,704		3,803,026			4,006,123
Inventory, net		1,130,668			889,526
Prepaid expenses		299,523			380,825
Deferred income taxes		257,630			557,630
Total current assets		12,773,920			13,261,269
Property and equipment, net of accumulated depreciation and
amortization of $10,304,504 and $9,031,136		4,681,577			5,545,492
Goodwill		1,120,058			1,120,058
Deferred income taxes		21,126			21,126
Other intangible assets, net of accumulated amortization of
$372,373 and $300,672		393,564			455,265
Deposits and other assets		82,671			80,992
Total assets	$	19,072,916		$	20,484,202
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Current portion of capital lease obligations	$	1,834,276		$	1,901,272
Dividends payable		--			2,710,817
Accounts payable		1,671,098			1,440,122
Accrued expenses and other liabilities		2,010,296			2,456,315
Total current liabilities		5,515,670			8,508,526
Capital lease obligations, net of current portion		1,872,710			2,670,942
Total liabilities		7,388,380			11,179,468
Shareholders' equity
Preferred stock, $0.001 par value, non-voting 10,000,000
shares authorized, no shares issued and outstanding		--			--
Common stock, $0.04 par value, 100,000,000 shares authorized
6,897,024 and 6,776,118 shares issued and outstanding		275,877			271,042
Additional paid-in capital		16,753,421			16,507,958
Accumulated deficit		(5,786,081	)		(8,062,324	)
Total Emergent Group equity		11,243,217			8,716,676
Non-controlling interest		441,319			588,058
Total shareholders' equity		11,684,536			9,304,734
Total liabilities and shareholders' equity	$	19,072,916		$	20,484,202

Emergent Group Inc. and Subsidiaries

Condensed Consolidated Statements of Income

(Unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2010			2009			2010			2009
Revenue	$	7,594,715		$	7,981,464		$	22,214,727		$	23,105,272
Cost of goods sold		4,607,609			4,802,495			13,465,898			13,839,056
Gross profit		2,987,106			3,178,969			8,748,829			9,266,216
Selling, general, and administrative expenses		1,566,503			1,490,174			4,522,235			4,442,338
Income from operations		1,420,603			1,688,795			4,226,594			4,823,878
Other income (expense)
Interest expense, net		(64,410	)		(85,692	)		(210,496	)		(261,681	)
Gain on disposal of property and equipment		--			5,500			64,323			8,050
Other income from affiliated entities, net		--			--			190,221			--
Other income, net		978			76			1,923			30,336
Total other income (expense)		(63,432	)		(80,116	)		45,971			(223,295	)
Income before provision for income taxes and
non-controlling interest		1,357,171			1,608,679			4,272,565			4,600,583
Provision for income taxes		(472,755	)		(553,000	)		(1,550,044	)		(1,604,634	)
Income before non-controlling interest		884,416			1,055,679			2,722,521			2,995,949
Non-controlling interests in income of
consolidated limited liability companies		(174,380	)		(225,023	)		(446,277	)		(597,030	)
Net income	$	710,036		$	830,656		$	2,276,244		$	2,398,919
Basic earnings per share	$	0.10		$	0.12		$	0.33		$	0.36
Diluted earnings per share	$	0.10		$	0.12		$	0.32		$	0.34
Basic weighted average shares outstanding		6,875,040			6,745,663			6,841,176			6,710,175
Diluted weighted-average shares outstanding		7,045,049			7,089,598			7,020,315			7,059,774

Supplemental Information --

Reconciliation of Net Income to Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2010		2009		2010		2009
Net income	$	710,036	$	830,656	$	2,276,244	$	2,398,919
Depreciation and amortization		593,796		568,549		1,773,679		1,620,057
Amortization - stock based compensation		78,044		63,280		220,230		170,494
Interest expense, net		64,410		85,692		210,496		261,681
Provision for income taxes		472,755		553,000		1,550,044		1,604,634
Total	$	1,919,041	$	2,101,177	$	6,030,693	$	6,055,785

Contact:  Emergent Group Inc.

                Bruce J. Haber

                (914) 235-5550, x. 12

                bhaber@primedical.net